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a b s t r a c t
The prevalence of food allergy has increased over the last 30 years and remains a disease, which
signiﬁcantly impacts on the quality of life of children and their families. Several hypotheses have been
formulated to explain the increasing prevalence; this review will focus on the hypothesis that dietary
factors may inﬂuence the development of food allergy. Historically, the prevention of food allergy has
focused on allergen avoidance. However, recent ﬁndings from interventional studies have prompted a
shift in the mind set from avoidance to early introduction of potentially allergenic foods. This review
aims to facilitate a better understanding of contemporary research studies that make use of early
introduction of common allergenic foods into infant diets as a preventative strategy against the devel-
opment of food allergy.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Background
The prevalence of food allergy has been on the rise over the last
30 years with 6e8% of children being affected worldwide; the
disease burden is higher for infants and preschool children.2e4 Food
allergy is primarily classiﬁed as immunoglobulin E (IgE)-mediated
food allergy, non-IgE mediated food allergy or mixed IgE and non-
IgE mediated food allergy.5 IgE-mediated food allergies are type 1
immediate hypersensitivity reactions with a quick onset of symp-
toms usually within a few hours of exposure to a food antigen
compared to non-IgE mediated food allergy where there is a
delayed onset of symptoms following exposure to a food.2 There is
strong evidence showing the signiﬁcant impact food allergies can
have on the quality of life of the children affected and their families
including emotional, psychological and ﬁnancial burdens.6e8 There
is as yet no cure for IgE-mediated food allergy and the main
treatment remains avoidance; thus, understanding the cause and
developing strategies for the prevention of allergy has been at the
forefront of current allergy research.
History of food allergy
In the 1960s, most infants were exposed to solids (comple-
mentary feeding) by 4 months of age9; however, in the 1970s new
guidelines were introduced recommending a delay in the intro-
duction of solids until after 4 months due to an assumption that
early introduction of gluten was contributing to a rise in coeliac
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disease which was observed at the time.10 The World Health
Organisation (WHO) recommended a further delay in the intro-
duction of solid food in the 1990s to 6 months of age, and advised
parents to delay the introduction of allergenic solids such as egg
and peanut to 10 months and 3 years, respectively.9 More specif-
ically, in 1998 the UK Department of Health suggested that atopic
pregnant and lactating women as well as children in the ﬁrst 3
years of life should avoid the consumption of peanuts.11,12 Despite
these recommendations being intended for ‘at risk’ families they
were more widely adopted.13,14 AWHO systematic global review in
2002, which looked at exclusive breastfeeding for 6 months, re-
ported no beneﬁts of introducing complementary foods between 4
and 6 months of age for allergy prevention; despite this, recom-
mendations for exclusive breastfeeding of infants in both devel-
oped and developing countries for the ﬁrst six months of age were
made.15 A similar stance was adopted in the United States with a
consensus document recommending that the optimal age for
selected foods should be 6 months, speciﬁcally dairy products at 12
months, hen's egg at 24 months and at the earliest, peanut, tree
nuts, ﬁsh and seafood at 36 months of age.16
Over the last few decades, despite these measures initiated to
prevent allergy by delaying the introduction of allergenic foods, the
prevalence of food allergy has continued to rise even in countries
where dietary avoidance is practiced. Factors such as genetic vari-
ation, ethnicity, gender, hygiene, maternal diet in pregnancy and
breastfeeding may all be contributing to the rising prevalence of
allergy. Several hypotheses as to the cause for the rising prevalence
of food allergies have been postulated and have been important in
driving current research aimed at the prevention of food allergy.
These hypotheses include the hygiene hypothesis, the vitamin D
hypothesis and the dual-barrier hypothesis.
Hygiene hypothesis
The hygiene hypothesis describes the protective inﬂuence early-
life microbial exposure has on the development of allergic dis-
eases.17 Strachen ﬁrst proposed that having older siblings had a
protective effect on the development of hay fever in younger sib-
lings, possibly due to exposure to common childhood infections,
but also maternal contact with older children in the prenatal
period.18 Since then, several studies have shown that various fac-
tors that increase exposure to pathogens, microbes and infections
after birth can inﬂuence the host microbiome and immune defence
system which plays a key role in the development of immune
regulation as well as the development of oral tolerance.19,20 Factors
such as the mode of delivery, communal childcare, pets at home
and birth order, which can inﬂuence exposure to micro-organisms,
have been shown to inﬂuence the development of allergic dis-
ease.19,21,22 The recent advances in our understanding of the role of
the microbiome and gastrointestinal barrier function has led to a
plethora of research in this area in relation to their role in food
allergy.23,24
Vitamin D hypothesis
A more recent hypothesis has been that low vitamin D levels
increase the risk of developing food allergy. Coincidentally, the rise
in food allergy has occurred in conjunction with the increasing
prevalence of vitamin D deﬁciency which has led to increased
research into understanding the link between the two conditions.25
In the HealthNuts population-based cohort study in Australia,
vitamin D insufﬁciency was found to be associated with challenge-
proven food allergy at 12 months of age.26 More in-depth research
into the genetic polymorphisms affecting vitamin D metabolism in
this cohort has shown that altering the bioavailability of serum
25(OH)D3 could have a role in the development of food allergy.27
Dual-barrier hypothesis
The dual-barrier hypothesis has also played a key role in trying
to explain the increasing prevalence of allergy. The most obvious
and dominant route of food allergen exposure is through con-
sumption, but allergen exposure may also occur through the skin
and possibly the respiratory tract if inhaled. Atopic children expe-
rience a T-helper type 2 (Th-2) allergen speciﬁc immune response
that occurs on exposure to a food allergen which results in the
production of IgE antibodies for that speciﬁc allergen.28 Non-atopic
children absorb these foreign antigens without causing an immune
host response, which allows for the development of oral toler-
ance.28 The dual-barrier hypothesis suggests that early allergic
sensitization to foods and environmental allergens occurs through
a damaged or weakened skin barrier (i.e. eczema, ﬁlaggrin (FLG)
loss-of-function mutations)19,29; thus there is a close relationship
that exists between food allergy and eczema. A recent study
showed that approximately 50% of childrenwith eczema developed
food allergy by 1 year of age.30 Strid et al. had previously demon-
strated that epicutaneous exposure to peanut protein in mice
prevented the normal induction of oral tolerance but also enhanced
Th2 responses including increasing IgE levels on gastrointestinal
exposure.31 This was further supported by Lack et al.'s paper which
showed that use of topical peanut-oil based emollient preparations
on children, which exposed them to peanut allergen through
inﬂamed skin, was associated with peanut allergy.32 Horimukai
et al. also found that having eczematous skin increased allergic
sensitization to egg white in the ﬁrst 8 months of life.30 Under-
standing the involvement of the skin barrier in food allergy has
included further research into the role of FLG, which is known to
play a vital role in epithelial barrier function and development of
eczema. Brough et al. looked at the effect of environmental peanut
exposure in a population-based birth cohort and found that chil-
dren who carried a FLG mutation had an increased risk of peanut
sensitization and allergy associated with early life environmental
peanut exposure.33 This is further supported by research from the
Isle of Wight cohort for which there was a signiﬁcant total effect
noted of FLGmutations on the risk of food allergy later in childhood
(10 years) but also an indirect effect between eczema and food
allergy sensitization in early childhood.34 Interestingly, recent work
by Kelleher et al. demonstrate that a permeable skin barrier on day
two of life is associated with food sensitization and allergy at 2
years of age, even in the absence of eczema.29 Studies into
improving the skin barrier in order to decrease the risk of food
allergy in children are underway; indeed, in a pilot study Simpson
et al. demonstrated in a cohort of neonates that daily emollient
applied from birth resulted in a 50% relative risk reduction in the
development of eczema at 6 months of age.35
The role of diet in food allergy
With the continual rise in prevalence of food allergy despite
advisory measures of avoidance, the last 10 years have witnessed
an increasing body of evidence based on epidemiological studies
that challenge the idea of dietary avoidance for the prevention of
food allergy.36 This has led to research looking into the alternate
strategy of early introduction of foods for the prevention of food
allergy.
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Maternal diet in pregnancy and lactation
The timing of when the sensitization to food or inhalant aller-
gens occurs (i.e. in utero or in the post-natal period) has been
considerably debated. There is little data available that supports the
manipulation of the maternal diet during pregnancy or lactation to
prevent food allergy. Kramer and Kakuma conducted a Cochrane
Systematic Review which included evidence from ﬁve trials, and
overall concluded that advising an antigen avoidance diet to
women during pregnancy and lactation was unlikely to reduce the
risk of giving birth to an atopic child.37 Similarly, there have been
studies that have shown no reduction in risk of cow's milk and egg
allergy in infants of mothers whowere avoiding cow's milk and egg
in pregnancy.38 Lack et al.'s cohort study using data from the Avon
Longitudinal Study of Parents and Children found no association
between the development of peanut allergy and maternal con-
sumption of peanuts during pregnancy, but also found no detect-
able speciﬁc IgE to peanuts in cord blood samples obtained.32
Similarly, Fox et al. found that maternal peanut consumption dur-
ing pregnancy and lactation had no effect on peanut sensitization in
infancy.12 However, Sicherer et al found that in their atopic cohort
of infants aged 3e15 months (CoFAR Study), maternal ingestion of
peanut during pregnancy was strongly associated with high peanut
sensitization.39
Breastfeeding
Breastfeeding has long been considered the infant feed of
choice; despite this widely accepted knowledge exclusive breast-
feeding rates and duration of breastfeeding remains sub-optimal in
most countries. For example, according to WHO, the highest rates
of exclusive breastfeeding for the ﬁrst 6 months of life occur in the
Eastern Mediterranean region of the world (40% of infants)
compared to only 29% of infants in theWestern Paciﬁc region of the
world.40 Nonetheless, breastfeeding has been considered to be a
factor that could inﬂuence food allergy development through
several mechanisms. These include potentially anti-allergic im-
mune properties in the milk, the possibility that prolonged
breastfeeding may delay allergen introduction, but also the pres-
ence of antibodies within breast milk that may combine with food
antigens to induce tolerance.1 However, there is limited evidence
on the direct impact breastfeeding has on the development of food
allergy. The majority of studies so far show no beneﬁt of breast-
feeding over cow's milk formulae on the development of allergy to
foods such as cow's milk, soya, and egg.38 Lack et al.'s study
investigating factors inﬂuencing food allergy found that the dura-
tion of breastfeeding was not signiﬁcantly associated with peanut
allergy andmothers of the childrenwho had peanut allergy had not
consumed more peanuts during breastfeeding compared to the
mothers of the children without peanut allergy.32
Timing of infant food introduction
The timing of food introduction and oral tolerance has been at
the forefront of paediatric food allergy research over the last
decade. The concept of oral tolerance is well understood in murine
models of which previous work has shown how early and regular
oral exposure induces clinical tolerance and immunological change
to food allergens.41,42 Further research in humans has also shown
that early exposure to food allergens can lead to oral tolerance,43
which we will discuss in greater detail below.
Cow's milk allergy
Cow's milk is the most common source of infant food allergy,
affecting 1.4e3.8% of young children.44 It can be IgE-mediated with
immediate reactions such as urticaria, angioedema and/or
anaphylaxis or non-IgE mediated which often manifests with skin
or gastrointestinal symptoms.45,46 A large observational cohort
study looked at the relationship between the age of introduction of
cow's milk and cow's milk sensitization at 2 years of age. A delay in
the introduction of cow's milk products was associated with an
increased risk of developing atopy at 2 years old, especially
eczema.47 A prospective study which aimed to determine risk
factors for developing cow's milk allergy found that infants started
on cow's milk protein formula within the ﬁrst 14 days of life had
lower rates of IgE-mediated cow's milk allergy compared to those
where cow's milk formula was introduced between 105 and 194
days of life, 0.05% versus 1.75%, respectively (p < 0.001).48 In
keeping with this data, Boyle et al.'s recent study conﬁrmed that
avoidance of cow's milk (i.e. using an extensively hydrolysed whey
formula) for the prevention of developing atopy at 12months, more
speciﬁcally eczema, in high-risk infants was not protective.49
Egg allergy
Egg allergy is the second most common food allergy with a
prevalence rate of approximately 2.5%.45,50 Several studies have
looked at the introduction of egg in various forms (i.e. baked,
cooked). The Solids Timing for Allergy Research (STAR) trial looked
at infants with moderate to severe eczema of which the interven-
tion group had egg (pasteurized raw whole egg powder) intro-
duced from 4 months of age compared to the control group who
avoided egg (rice powder).42 Although the results were not statis-
tically signiﬁcant, a lower proportion of infants in the intervention
group were diagnosed with IgE-mediated egg allergy compared to
the control group, 33e51%, respectively (relative risk 0.65, CI
0.38e1.11, p ¼ 0.11).42 Nwaru et al. found that in their cohort of 994
Finnish children, having their ﬁrst introduction of eggs occur when
theywere 10.5months or older was associatedwith sensitization to
food allergens at 5 years of age.51 Data from the Australian
HealthNuts cohort also showed that delayed introduction of egg
until 10e12 months or >12 months old was associated with a
signiﬁcantly increased risk of egg allergy compared to those infants
who had early introduction at 4e6 months of age.52 Furthermore,
in the early introduction group, ﬁrst exposure to cooked egg
reduced the risk of egg allergy compared to ﬁrst exposure of egg in
baked goods (OR, 0.2, 95% CI 0.06e0.71).52 Similarly, Leonard et al.
found that the initiation of baked egg diet accelerated the devel-
opment of egg tolerance compared to strict avoidance.53 Not only
may the timing of introduction of egg be important, but the form in
which egg is introducedmay have an impact on the development of
tolerance. Further large trials are being conducted including the
Hen's Egg Allergy Prevention (HEAP) trial.54 This study aimed to
look at the introduction of egg (pasteurized egg white powder) in
the general population with infants receiving egg or placebo three
times a week starting at age 4e6 months until 12 months. Provi-
sional results showed that the early consumption of pasteurized
hen's egg was not effective in preventing egg allergy at 12 months
of age. The majority of the infants who underwent double-blind
placebo-controlled food challenges (94%, 16/17) had a positive
challenge and in fact, two of the children in the intervention group
reacted to the pasteurized egg white powder on ﬁrst exposure at
home (including one that had anaphylaxis).
More recently, the Enquiring About Tolerance (EAT) study,55,56
which is a randomized controlled trial looking at the early intro-
duction of six common food allergens at 3 months of age (early
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introduction group) alongside breastfeeding compared to exclu-
sively breast-fed infants (standard introduction group), found that
the prevalence of egg allergy was signiﬁcantly lower in the early-
introduction group (2.4% vs. 7.3%, p ¼ 0.01) in the per-protocol
analysis. Egg allergy occurred in 3.7% of the early introduction
group compared to 5.4% in the standard introduction group (rela-
tive reduction 31%, p ¼ 0.17). In the EAT Study, egg was eaten as
whole hard-boiled egg and the per protocol uptake for egg inges-
tionwas lower compared to the ingestion of the other EAT foods, i.e.
peanut and milk, but higher than for sesame, ﬁsh, and wheat
(which was the last food to be introduced on the study). The low
uptake of egg may be related to texture, smell or the logistic de-
mands of boiling and preparing an egg into a feed appropriate for
infants. Additional trials are underway such as the Beating Egg
Allergy Trial (BEAT)57 and the Egg Allergy Prevention Trial,58 which
should provide uswith greater insight into the safety and efﬁcacy of
early egg introduction.
Peanut allergy
Although the prevalence of peanut allergy is less common than
milk or egg allergy, it can induce life-threatening anaphylaxis and
has been on the rise.45 The early ecological study by Du Toit et al.59
raised the question whether early peanut introduction may be an
ideal strategy for the prevention of peanut allergy. The study looked
at infants with peanut allergy in Israel compared to those in the UK
and found the prevalence of peanut allergy in the UK to be signif-
icantly higher in the UK compared to Israel (1.85% versus 0.17%,
p < 0.001). Further analysis revealed that peanut was introduced
earlier and eaten more frequently and in larger quantities in Israeli
infants compared to UK children. Israeli infants between ages 8e14
months were consuming about 7.1 g of peanut protein per month
compared to 0 g of peanut protein in children in the UK (p < 0.001).
The 10-fold increased prevalence of peanut allergy in UK children
even after differences in atopy, genetics, social class and peanut
allergenicity were accounted for, brought forth the question of
whether early peanut introduction and regular consumption may
be contributing to the development of peanut allergy. These ﬁnd-
ings led to the design of the Learning Early about Peanut Allergy
(LEAP) study.60,61 The LEAP study was a randomized controlled
study that aimed to assess oral tolerance induction of peanut in
high-risk children aged between 4 and 11 months of age in the UK.
Infants were randomized to consuming peanut products at least 3
times a week (average of 6 g of peanut protein a week) or
completely avoiding any peanut products until 60 months of age.
The results from the study demonstrated that in this cohort of high-
risk atopic children, early introduction and regular ongoing con-
sumption of peanut resulted in a signiﬁcant reduction (81% relative
reduction, intention to treat analysis) in the number of children
with peanut allergy at 60 months of age compared to those who
avoided peanut. The intention-to-treat analysis showed that in the
peanut avoidance group, 17.2% of the children had challenge-
proven peanut allergy at 60 months of age compared to 3.2% in
the peanut consumption group. From a safety perspective, 7 of the
319 children randomized to the peanut consumption group reacted
to peanut at their baseline oral food challenge (OFC). However, the
reactions were not severe enough to require adrenaline and
choking on peanut foods was not reported. Many of the participants
were breastfeeding at the beginning of LEAP but this was not
affected by the early-life introduction of peanut. There were no
differences in height, weight or body mass indexda measure of
body fatdbetween the peanut consumers and avoiders.62 This was
true evenwhen the researchers compared the subgroup of children
who consumed the greatest amount of peanut protein to thosewho
avoided peanut entirely. In general, the peanut consumers easily
achieved the recommended level of 6 g of peanut protein per week,
consuming 7.5 g weekly on average. Uptake of peanut consumption
was achieved within the ﬁrst month with participants tolerant of
peanut eating increasing amounts of peanut with age and peanut in
different foods. LEAP consumers made favourable food choices
compared to avoiders. For example, consumers ate fewer chips and
savoury snacks. Both groups had similar total energy intakes from
food and comparable protein intakes. Peanut consumers enjoyed
higher fat intakes as compared to avoiders (the beneﬁts of which
are currently being debated in the nutritional literature) and
avoiders had higher carbohydrate intake.62 LEAP participants ran-
domized to peanut consumption had a higher intake of omega 6
polyunsaturated fatty acids (PUFAs), as peanut is rich in PUFAs.
Compared to the avoiders at all study time points, the higher ratios
of omega 6 to omega 3 intake were not associated with differences
in the prevalence of protocol-deﬁned seasonal allergic rhino-
conjunctivitis, perennial allergic rhino-conjunctivitis, eczema or
asthma. Together, these ﬁndings demonstrate the acceptability and
safety of this intervention. The LEAP study was able to demonstrate
both primary and secondary prevention of the development of
peanut allergy by early introduction, i.e. both participants who
were sensitized to peanut and those who were not sensitized to
peanut at baseline (based on skin prick test (SPT) and speciﬁc-IgE
levels) had reduced peanut allergy at 60 months if peanut was
introduced early. The reduction in peanut allergy translates to a
number needed to treat (NNT) of 8.5 for participants with a nega-
tive SPT response to peanut (no measurable wheal) and NNT of 4.0
for the participants who had a baseline low-positive peanut SPT
response (wheal of 1e4 mm).
The LEAP-On study63 was an extension study to LEAP, which
investigated whether children who consumed peanut remained
protected against developing peanut allergy even after cessation of
peanut consumption for a period of 12 months. A total of 556
participants (88.5% (556/628)) from the primary trial were enrolled
in the follow-on study and the rate of adherence to avoidance was
high (90.4% in the peanut-avoidance group, 69.3% in the peanut-
consumption group). At 72 months, peanut allergy remained
signiﬁcantly higher in the peanut-avoidance group compared to the
peanut-consumption group, 18.6% vs 4.8% (p < 0.001), respectively.
These clinical ﬁndings were associated with immunological
changes (levels of Ara h 2 speciﬁc peanut IgE, peanut speciﬁc IgE
and IgG4 levels) suggestive of immune tolerance. For example,
participants with peanut allergy at 72 months had higher levels of
Ara h 2 speciﬁc IgE compared to those who did not have peanut
allergy and the mean level of Ara h 2 speciﬁc IgE which had
declined signiﬁcantly in the peanut consumption group in the
primary trial (p < 0.001) remained low at 72 months, after 12
months of peanut avoidance. Contrastingly, the mean levels of Ara
h 2 speciﬁc IgE in the peanut avoidance group were signiﬁcantly
higher at 60 months and 72 months compared to the peanut con-
sumption group (p < 0.001). As for IgG4 levels and the ratio of
peanut speciﬁc IgG4:IgE, they were both signiﬁcantly higher in the
peanut consumption group compared to the peanut avoidance
group (p < 0.001) at 60 months, but also at 72 months after a
yearlong period of avoidance (p < 0.001). However, in the con-
sumption group, values of peanut IgG4 had started to decrease,
even at 30months of age (when peanut consumptionwas ongoing).
LEAP-On demonstrates that for the peanut consumption group,
their non-allergic status remained stable over 12 months of
avoidance. Therefore, the key ﬁnding of the LEAP studies is that
early introduction and consumption of peanut until 60 months of
age causes a reduction in peanut allergy that persists at 72 months
of age, even with a 12-month period of avoidance. Follow-on
studies of this cohort are planned to determine if the effects of
early tolerance continue to persist for longer.
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Other food allergens
Early introduction of other food allergens has been studied in
cross-sectional studies that use surrogate markers (other than
OFC) for the diagnosis of food allergy. For example, Kull et al. found
that regular consumption of ﬁsh in the ﬁrst year of life was
associated with a reduced risk of allergic disease (OR, 0.76; 95% CI
0.61e0.94) and sensitization to food and aeroallergens (OR, 0.76;
95% CI 0.58e1.0) at 4 years of age.64 However, the diagnosis of ﬁsh
allergy was based on positive speciﬁc IgE level of 0.35 kUA/l
rather than double-blinded OFCs, which are the gold standard for
diagnosis of food allergy.65 Also, the prevalence of ﬁsh
Fig. 1. EAT Study Primary Outcome e Food Allergy. The prevalence of IgE mediated food allergy is shown to one or more of the six intervention foods (Panel A), to peanut (Panel B)
and to egg (Panel C). The ﬁrst column shows the intention-to-treat analysis, the second column the per-protocol analysis and the third column an adjusted per-protocol analysis. The
latter was a conservative per-protocol analysis that adjusted the standard introduction group food allergy prevalence by subtracting the number of baseline early introduction group
participants who were challenge positive at enrolment and completed the study with a conﬁrmed food allergy from both the numerator (the number of allergic standard
introduction group participants) and the denominator (the number of standard introduction group per-protocol adherent participants). p Values are based on chi-square analyses
(or Fisher's exact test where appropriate).
From Perkin M, Logan K, Tseng A, Raji B, Ayis S, Peacock J et al. Randomized trial of introduction of allergenic foods in breast-fed infants. N Engl J Med 2016; 374: 1733e43. Reprinted
with permission.
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sensitization is not as common as foods such as egg, milk and
peanut66,67 thus making it more challenging to extrapolate this
data to other foods allergens. Similarly, a study looking at intro-
duction of wheat found that children exposed to cereals (wheat,
barley, rye, oats) after 6 months of age had an increased risk of
developing wheat allergy compared to those childrenwhere it was
introduced before 6 months.68 Upcoming research work such as
the ProNut study,69 which aims to evaluate the cross-reactivity in
nut allergic children through OFCs, may provide us with greater
insight into tree nut allergens.
The EAT study56 also provides important insight into oral
tolerance for multiple allergenic foods in a general UK paediatric
population. Over 1000 infants were recruited with the initial
criteria prior to randomization being that infants had to have been
exclusively breast-fed from birth until enrolment at 3 months of
age. In the study, the intervention group had six potentially aller-
genic foods (cow's milk, egg, wheat, sesame, ﬁsh, peanut) intro-
duced into their diets by 4 months of age compared to the control
group which followed standard UK government advice of exclu-
sively breastfeeding until 6 months of age with no introduction of
allergenic foods before 6months. The randomized sequence of food
introductions for the early introduction group was cow's milk
(yogurt) ﬁrst, followed by peanut, egg, sesame and whiteﬁsh in
random order with wheat introduced last. The main outcomewas a
challenge proven diagnosis of allergy to one ormore of the six foods
at 1 year and 3 years of age. The intention-to-treat (ITT) analysis
showed that 7.1% of the infants in the standard group developed
food allergy to one or more of the six interventional foods
compared to 5.6% in the intervention group (p ¼ 0.32). In the per-
protocol analysis, the prevalence of any food allergy was signiﬁ-
cantly lower in the early-introduction group compared to the
standard-introduction group (2.4% vs 7.3%, p ¼ 0.01). Furthermore,
the prevalence of peanut allergy (0% vs 2.5%, p ¼ 0.003) and egg
allergy (1.4% vs 5.5%, p ¼ 0.009) was less in the early-introduction
group compared to the standard-introduction group (Fig. 1).
Favourable cutaneous immunological changes were also noted;
in the ITT analysis the risk of having a positive SPT to any food was
22% lower in the early introduction group compared to the stan-
dard introduction group at 12 months of age and 36 months of age,
p ¼ 0.07 and p ¼ 0.47, respectively. Although both were not sig-
niﬁcant, a signiﬁcant difference was seen in the per-protocol ana-
lyses. Both at 12 months and 36 months, the early introduction
group had a signiﬁcantly lower rate of SPT to any food compared to
the standard introduction group, 42% (p ¼ 0.01) and 67%
(p ¼ 0.002), respectively.
Adherence
In the EAT study, the rate of adherence in the standard intro-
duction group was high with 92.9% (524/564) of the participants
meeting the per protocol criteria. The early introduction group
proved to be more challenging with only 42.8% (208/486) of the
participants being per protocol compliant. More speciﬁcally, in the
early introduction group the food that was tolerated least was hen's
egg (43.1%). Further analysis included calculation of the weekly
mean consumption of egg and peanut protein, which was divided
into quartiles between enrolment and 6 months of age. Using this
data, predictive probability plots were generated which showed
that higher consumption of peanut and egg was associated with
lower sensitization and prevalence of allergy to the speciﬁc food.
Importantly, what was adhered to extremely well was exclusive
breastfeeding. Furthermore, for the infants who were in the
standard-introduction group, they had to continue exclusive
breastfeeding until at least 5 months of age.
In the LEAP study, the overall adherence rate of the two assigned
interventions was high (92.0%). This was similarly reﬂected in the
LEAP-On study with an overall adherence to the intervention of
peanut avoidance in the follow-up group being 80.0%. There are
many possible explanations for the differences in adherence rates
between the studies including factors relating to the food/s (e.g.
yoghurt is easily served, and a common infant feed), mother and
family (education and ethnic differences), and ongoing study sup-
port (LEAP offered signiﬁcantly more study contact than did EAT).
Non-IgE mediated allergy
Most of the focus on early intervention studies has been on IgE-
mediated food allergy. However, of increasing interest is the
recognition and diagnosis of non-IgE mediated food allergy, which
often presents with a delayed onset of symptoms that are usually
gastrointestinal or dermatological in nature.70 The EAT study
collected data on parental reporting of non-IgE mediated symp-
toms such as colic, vomiting, posseting, diarrhoea and constipation.
They found that infants in the early intervention group reported
signiﬁcantly more non-IgE type symptoms e.g. eczema ﬂares and
colic, than the standard intervention group at 4e6 months of age,
8.6% and 3.8%, respectively (p < 0.001). However, rates of non-IgE
symptoms at any time point were equivalent between groups
suggesting that the introduction of the study foods was associated
with the reporting of these symptoms regardless of when they
were introduced. Speciﬁcally, 11.9% of participants in the early
introduction group reported non-IgE type symptoms to one or
more of the early introduction foods at any point (4e12 months)
compared to 9.6% of the standard introduction group (p ¼ 0.20).
Further research into understanding whether early intervention
studies can impact the development of non-IgE mediated food al-
lergies will be important to better understand all types of child-
hood allergic disease.
Future research
Over the last few years, based on the ﬁndings from LEAP, there
has been a change in practice by clinicians and advice given to
parents of children at risk of peanut allergy. Consensus statements
from various global allergy, paediatric and dermatology societies
have been published encouraging the early introduction of peanut
to infants at risk of developing food allergy.71e74 From this, Aus-
tralasian guidelines have been updated to include the introduction
of allergenic solid foods including peanut butter, cooked egg, dairy
and wheat products to all children in the ﬁrst year of life, including
those at high risk of allergy.75
The exact timing of early dietary interventions remains an
important question that will require further research. In the LEAP
study, 76 of the 194 patients excluded had SPTgreater than 4mm in
diameter and were considered too high-risk for the study. Of the
children randomized into groups for the study,15.3% (98/640) had a
positive SPT result on initial assessment. In the EAT study, 5.1% (33/
652) of the early-introduction group had a positive SPT to one of the
six foods being introduced. OFC were performed for these 33 in-
fants and 7 infants had a positive challenge to at least one of the
allergenic foods. The children in the EAT study were 3 months of
age at the time these assessments were made suggesting that
sensitization may be occurring even earlier than 3e4 months of
age. Although a multitude of factors (i.e. gender, genetics, envi-
ronmental factors) are likely to contribute to this, it questions the
timing at which infants should be exposed to potential allergens. If
early introduction is truly the best strategy as shown by the work
already done, should future preventative strategies aim to expose
children to food allergens earlier to prevent food allergy and if so,
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what methods would be safe and effective? Both in the LEAP and
EAT studies, safety of early introduction was measured. The LEAP
study reported no signiﬁcant differences in serious adverse effects
or rates of hospitalization between the peanut consumption and
avoidance groups. Similarly, the EAT study concluded that early
introduction was safe with no cases of anaphylaxis occurring dur-
ing the initial introduction regimen as well as no effects on growth
or breastfeeding of the infants. Choking related to a study food was
not reported for both studies. However, the LEAP study design
excluded 9.1% of the infants who were initially screened because
they had SPT wheals >4 mm in diameter on baseline testing and
were classiﬁed as high risk. They went on to have an OFC at 60
months of age and it was found that a SPT > 4 mm in this popu-
lation of infants was predictive of peanut allergy at 60 months of
age. It is in these childrenwhere potential future work is needed, as
it is currently unknownwhether early intervention in this group of
children would be safe, effective and tolerated.
Conclusions
The evidence supporting the role of early introduction of po-
tential allergens in the development of oral tolerance to prevent
food allergy is mounting. Although there are still questions as to the
timing and also which allergens can be introduced safely and with
effect, a shift from recommending avoidance of common food al-
lergens to early consumption strategies to prevent the develop-
ment of food allergy is occurring. It appears that the window of
opportunity for intervention is starting to close upon reaching the
milestone of sitting and is almost entirely closed upon reaching the
milestone of walking. Studies such as the LEAP study have already
been inﬂuential in recommendations in order to prevent the
development of peanut allergy. The EAT study results, in the per
protocol population, support the LEAP ﬁndings and also demon-
strate a reduction in egg allergy in the early introduction group. A
clinical reduction in allergy could not be demonstrated for the other
food allergens in EAT, but there were trends towards the reduction
of both peanut and egg and the ingestion of these allergenic foods
proved nutritionally safe. Indeed, there were many favourable
nutritional outcomes related to early peanut introduction and
ongoing consumption in the LEAP study. These recent advances
towards food allergy prevention are extremely promising, but
further work is required to establish if they will be as effective for
other common food allergens.
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